PMU62 - ECONOMIC EVALUATION OF MESALAZINE 4G (SALOFALK®) IN THE TREATMENT OF PATIENTS WITH ULCERATIVE COLITIS LOCATED IN THE RECTUM AND SIGMOID
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1898
https://www.valueinhealthjournal.com/article/S1098-3015(18)35200-8/fulltext
Title :
PMU62 - ECONOMIC EVALUATION OF MESALAZINE 4G (SALOFALK®) IN THE TREATMENT OF PATIENTS WITH ULCERATIVE COLITIS LOCATED IN THE RECTUM AND SIGMOID
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35200-8&doi=10.1016/j.jval.2018.09.1898
First page :
Section Title :
Open access? :
No
Section Order :
1261